Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

289
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
289
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

181
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
181
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

209
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
209

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Community-led vaccine strategies to boost COVID-19 vaccine uptake among racialized immigrant groups in Parc Extension, Quebec: a strengths-based exemplar study.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitus.

Diabetes research and clinical practice·2026
Same author

A Case of Oxyntic Gland Neoplasm Incidentally Found During Upper Endoscopic Screening.

The Korean journal of helicobacter and upper gastrointestinal research·2026
Same author

Cross-cultural validation and reliability of the Korean version of the Haemophilia Activities List.

Blood research·2026
Same author

Synergistic dual doping and directed structural engineering of 2D cobalt tellurium nanoarchitectures for practical-level overall water splitting.

Materials horizons·2026
Same author

Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus.

Endocrinology and metabolism (Seoul, Korea)·2026

相关实验视频

Updated: Jul 9, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K

在2型糖尿病患者的初始组合疗法.

Ji Yoon Kim1, Nam Hoon Kim2

  • 1Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Endocrinology and metabolism (Seoul, Korea)
|November 30, 2023
PubMed
概括
此摘要是机器生成的。

对2型糖尿病 (T2D) 的初始组合疗法比逐步方法提供了更好的血糖控制和更少的并发症. 临床医生应该权衡好处与潜在危害,以获得最佳的患者结果.

关键词:
糖尿病,第二类糖尿病.药物治疗,组合治疗.血糖控制 血糖控制 血糖控制低血糖剂是一种低血糖剂.

更多相关视频

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

4.0K

相关实验视频

Last Updated: Jul 9, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

4.0K

科学领域:

  • 内分泌学 在内分泌学.
  • 代谢疾病 代谢疾病
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 2型糖尿病 (T2D) 是一种渐进的疾病,在实现持久的血糖控制方面存在挑战.
  • 密集的血糖控制对于预防糖尿病相关并发症至关重要.
  • 单疗法或逐步补充方法往往不足以长期控制血糖水平.

研究的目的:

  • 审查关于T2D初始组合治疗的文献.
  • 评估初始组合治疗的好处和缺点.
  • 根据患者的特征和临床情况,建议实施初始组合治疗的最佳策略.

主要方法:

  • 对T2D初始组合治疗研究的文献综述.
  • 对临床试验数据的分析,比较组合疗法与单一疗法和逐步方法.
  • 评估有关β细胞功能和并发症率的证据.

主要成果:

  • 初始组合疗法与单一疗法或逐步方法相比,显示出更好的血糖控制.
  • 新出现的证据表明,初始组合疗法可以保持β细胞功能并减少并发症.
  • 成本效益和不良事件仍然是组合治疗的重要考虑因素.

结论:

  • 最初的组合疗法是管理T2D的可行选择,提供显著的血糖效益.
  • 在实施组合疗法时,需要仔细考虑成本和不良事件.
  • 个性化策略平衡好处和危害对于最佳的T2D管理至关重要.